PanAgora Pharma

What PanAgora Pharma does

PanAgora Pharma is a US-based pharmaceutical event management company operating as a division of PanAgora Conference Group, LLC. Founded in 2013 and headquartered in New York, the company operates with 1-10 employees and organizes a portfolio of seven annual conference series targeting senior-level life sciences, pharmaceutical, clinical research, drug development, and digital health executives. Lead executives are co-founder and CEO Doug Lavender and co-founder and COO Thomas Hanley.

Its event portfolio spans the Digital Breakthrough for Pharma Summit, Digital Biomarkers Summit, Clinical Trial Innovation Summits (EU and USA), Digital Implementation Summit, Pharma CX AI & Tech Summit, and the flagship Pharma CX Summit (now in its 14th year). Events are physically hosted at venues provided by major pharmaceutical sponsors—Bristol Myers Squibb (Princeton Pike), Roche (Basel), Genentech (South San Francisco), and Pfizer (Cambridge)—with attendance ranging from approximately 125 senior executives at the Pharma CX AI & Tech Summit to 350+ global experts at the Digital Biomarkers Summit.

The business model is event-driven, generating revenue through two streams: attendee registration fees (transaction model) and corporate sponsorship/advertising revenue (sponsorship model). Registration pricing is not publicly disclosed and is acquired through an online checkout portal. The go-to-market is relationship-led through host-sponsor partnerships with top-tier pharma companies, combined with direct online registration and event-driven demand generation.

Name

PanAgora Pharma

Legal name

PanAgora Conference Group, LLC

Website

https://events.panagorapharma.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

1–10 employees

Short description

PanAgora Pharma is a US-based pharmaceutical event company operating annual conferences for senior pharma, clinical trials, digital health, and CX executives. Its seven-event portfolio is hosted with major pharma sponsors including Bristol Myers Squibb, Roche, Genentech, and Pfizer across US and EU venues.

Ownership category

akta.pro rank

Product category

Pharmaceutical and Life Sciences Conferences / B2B Event Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Healthcare, Medical Devices & Pharma Shows Organizers (THAHABAH)

Keywords

• Pharmaceutical conferences
• Life sciences events
• Clinical trial summits
• Pharma marketing events
• Digital health summits

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Operations, Marketing or Sales, Personnel, Technology or R&D

Revenue model

1. Event Registration Fees: Revenue generated from attendees paying to register for pharmaceutical and life sciences conferences and summits organized by PanAgora Pharma.
2. Sponsorship: Revenue from pharmaceutical and life sciences companies sponsoring events, with host sponsors like Bristol Myers Squibb, Roche, Genentech, and Pfizer hosting specific summits.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

PanAgora Pharma organizes and produces annual B2B conferences and summits serving the pharmaceutical and life sciences industries. Its portfolio includes the Pharma CX Summit, Pharma CX AI & Tech Summit, Digital Breakthrough for Pharma Summit, Digital Biomarkers in Clinical Trials Summit, Clinical Trial Innovation Summit (EU and USA), and Digital Implementation Summit. Events target senior-level life sciences, research, drug development, and digital health executives, and are delivered through host-sponsor arrangements with major pharma companies such as Bristol Myers Squibb, Roche, Genentech, and Pfizer.

Product overview

PanAgora Pharma is a conference and event management company that organizes pharmaceutical and life sciences industry events. The company operates a portfolio of event series including the Digital Breakthrough for Pharma Summit, Digital Biomarkers in Clinical Trials Summit, Clinical Trial Innovation Summits (EU and USA), Digital Implementation Summit, Pharma CX AI & Tech Summit, and the annual Pharma CX Summit. These events serve as professional networking and knowledge-sharing platforms for senior-level life sciences, research, drug development, and digital health executives, focusing on topics such as digital health innovation, clinical trial advancement, patient-centricity, and customer experience technology in the pharma industry.

Differentiator

Problem solved

Functional benefit

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Four partnerships are on record, tiered core.

• Bristol Myers Squibb (BMS)coreStrategic or Co-development PartnerBristol Myers Squibb serves as host sponsor for the Digital Breakthrough for Pharma Summit USA 2026. The event will be held at BMS Princeton Pike in Lawrence Township, NJ on June 2, 2026.
• RochecoreStrategic or Co-development PartnerRoche serves as host sponsor for multiple summits including the 9th Annual Digital Biomarkers Summit (June 23, 2026) and 6th Annual Clinical Trial Innovation Summit EU (June 24, 2026), both held at Roche Headquarters in Basel, Switzerland.
• GenentechcoreStrategic or Co-development PartnerGenentech serves as host sponsor for the 3rd Annual Clinical Trial Innovation Summit USA 2026, to be held at Genentech Campus in South San Francisco, CA on October 13, 2026.
• PfizercoreStrategic or Co-development PartnerPfizer serves as host sponsor for the 9th Annual Digital Implementation Summit 2026, to be held at Pfizer Innovation Lab in Cambridge, MA on November 3, 2026.

Scale indicators7 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Informa (Pharma / Connect division): Global events and information services giant operating large-scale pharma and life sciences conferences (e.g., CPHI Worldwide, Bio-Europe, Festival of Biologics) targeting the same senior pharma executive audience as PanAgora. Scaled incumbent that competes for sponsorship dollars and speaker attention in adjacent pharma sub-verticals.
• Reuters Events (Pharma): Runs pharma-focused conferences (e.g., Pharma Customer Engagement, Clinical Trials Innovation) addressing digital health, clinical operations, and CX — the exact theme cluster PanAgora plays in. Large incumbent with superior marketing reach and speaker access.
• Drug Information Association (DIA): Global, member-driven life sciences association running major annual conferences (DIA Annual Meeting, DIA Global Forum) covering regulatory, clinical, and pharmacovigilance topics. Adjacent competitor for sponsor attention at pharma conferences and alternative venue for the same senior executive audience.
• Terrapinn: Global B2B events company running large-scale life sciences and pharma conferences (e.g., Pharma events in the US and Europe) at the same senior executive level. While broader in scope than PanAgora, it competes for the same sponsorship wallet.

Direct peers

• The Conference Forum: Niche conference organizer focused on the pharmaceutical and biotech industry, producing events such as TIDES, Clinical Trial Innovation Summit, and Patients as Partners — overlapping directly with PanAgora's clinical trials and patient-centricity franchise.
• Hanson Wade: Specialized B2B conference organizer running deep, niche-focused summits across life sciences and pharma (e.g., decentralized trials, biomarker, patient engagement). Closely comparable business model — small team, high-end summits with pharma and biotech sponsors.
• ExL Events: Pharma and life sciences conference organizer producing events across clinical operations, marketing, and digital health (now part of Informa Connect). Competes head-to-head for sponsor dollars and attendee mindshare in similar pharma sub-verticals.
• Arena International: B2B conference organizer with a dedicated life sciences portfolio covering clinical trials, biopharma R&D, and pharma commercialization — directly overlapping with PanAgora's event categories and target executive audience.
• Q1 Productions: Niche business conference organizer with a strong pharmaceutical industry portfolio covering clinical operations, biotech manufacturing, and patient access — directly comparable business model and customer base to PanAgora.

Emerging players

• Impatient Health: Emerging events and content platform for life sciences commercial and digital health leaders. Focuses on the same pharma marketing, CX, and digital health executive audience that PanAgora targets through its Pharma CX Summit and Digital Health events.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/panagorapharma

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PanAgora Pharma